These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 352138)

  • 21. [Alcoholic liver diseases in young women].
    Becker U; Federspiel B
    Ugeskr Laeger; 1983 Jan; 145(2):102-3. PubMed ID: 6845453
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibodies to alcohol altered liver cell determinants in patients with alcoholic liver disease.
    Neuberger J; Crossley IR; Saunders JB; Davis M; Portmann B; Eddleston AL; Williams R
    Gut; 1984 Mar; 25(3):300-4. PubMed ID: 6199263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Delayed hypersensitivity in postnecrotic and alcoholic cirrhosis].
    González San Martin F; Díaz-Rubio E; Diaz-Rubio García M; Martínez Moreno I; de Miguel Gallego JL
    Rev Esp Enferm Apar Dig; 1978 Nov; 54(5):505-12. PubMed ID: 746227
    [No Abstract]   [Full Text] [Related]  

  • 24. Antibodies against acetaldehyde-modified epitopes: presence in alcoholic, non-alcoholic liver disease and control subjects.
    Worrall S; De Jersey J; Shanley BC; Wilce PA
    Alcohol Alcohol; 1990; 25(5):509-17. PubMed ID: 1708257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of antibodies to acetaldehyde-albumin conjugates in alcoholic liver disease.
    Teare JP; Carmichael AJ; Burnett FR; Rake MO
    Alcohol Alcohol; 1993 Jan; 28(1):11-6. PubMed ID: 8471080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular immune responses and lymphocyte populations in chronic hepatitis.
    Pár A; Bajtai G; Barna K; Ambrus M; Kovács M; Balázs M; Palka I; Szalók I
    Acta Med Acad Sci Hung; 1979; 36(1):31-43. PubMed ID: 316635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased stable E rosette-forming cells in alcoholic liver disease.
    de Moura MC; Ramalho F
    Biomedicine; 1980 Nov; 33(7):220-1. PubMed ID: 6971655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of T cell activation pathways in patients with liver cirrhosis, impaired delayed hypersensitivity and other T cell-dependent functions.
    Schirren CA; Jung MC; Zachoval R; Diepolder H; Hoffmann R; Riethmüller G; Pape GR
    Clin Exp Immunol; 1997 Apr; 108(1):144-50. PubMed ID: 9097923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-mediated immunity to acetaldehyde in alcoholic liver disease demonstrated by leukocyte migration test.
    Actis GC; Ponzetto A; Rizzetto M; Verme G
    Am J Dig Dis; 1978 Oct; 23(10):883-6. PubMed ID: 362901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating immune complexes and complement concentrations in patients with alcoholic liver disease.
    Gluud C; Jans H
    J Clin Pathol; 1982 Apr; 35(4):380-4. PubMed ID: 7076865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Alcoholic fatty liver, alcoholic hepatitis and alcoholic cirrhosis. Drinking behavior and incidence of clinical, clinico-chemical and histological findings in 282 patients].
    Bode JC; Kruse G; Mexas P; Martini GA
    Dtsch Med Wochenschr; 1984 Oct; 109(40):1516-21. PubMed ID: 6236965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphocytotoxicity in acute and chronic alcoholic liver disease: "in vitro" study on effector cells.
    Miglio F; Stefanini GF; Bernardi M; Facchini A; Mariani E; Gasbarrini G
    Gastroenterol Clin Biol; 1979; 3(6-7):531-5. PubMed ID: 535720
    [No Abstract]   [Full Text] [Related]  

  • 33. [Lymphocytotoxicity in alcoholic hepatitis: evalutation of effector cells].
    Stefanini GF; Mariani E; Facchini A; Serra S; Miglio F
    Boll Soc Ital Biol Sper; 1979 Mar; 55(5):404-10. PubMed ID: 553595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular cytotoxicity against autologous hepatocytes in alcoholic liver disease.
    Poralla T; Hütteroth TH; Meyer zum Büschenfelde KH
    Liver; 1984 Apr; 4(2):117-21. PubMed ID: 6610087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B and A virus antibodies in alcoholic steatosis and cirrhosis.
    Gluud C; Aldershvile J; Henriksen J; Kryger P; Mathiesen L
    J Clin Pathol; 1982 Jul; 35(7):693-7. PubMed ID: 6284803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxic T lymphocytes and natural killer cells display impaired cytotoxic functions and reduced activation in patients with alcoholic hepatitis.
    Støy S; Dige A; Sandahl TD; Laursen TL; Buus C; Hokland M; Vilstrup H
    Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G269-76. PubMed ID: 25501547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carcinoembryonic antigen (CEA) in patients with alcoholic liver diseases.
    Bell H; Orjasaeter H; Lange HF
    Scand J Gastroenterol; 1979; 14(3):273-9. PubMed ID: 441676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of plasma complement activation in severe acute alcoholic hepatitis.
    Bird GL; Lau JY; Davies ET; Williams RS
    Alcohol Clin Exp Res; 1995 Dec; 19(6):1537-40. PubMed ID: 8749823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T rosettes in alcoholic cirrhosis of the liver.
    Berenyi MR; Straus B; Avila L
    JAMA; 1975 Apr; 232(1):44-6. PubMed ID: 1090766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver membrane antibodies in alcoholic liver disease: 1. prevalence and immunoglobulin class.
    Burt AD; Anthony RS; Hislop WS; Bouchier IA; MacSween RN
    Gut; 1982 Mar; 23(3):221-5. PubMed ID: 7040177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.